Kos Pharmaceuticals to pay more than $41 million to resolve kickback and off-label promotion allegations
Compliance Monitor, December 15, 2010
Want to receive articles like this one in your inbox? Subscribe to Compliance Monitor!
Kos Pharmaceuticals agreed to pay more than $41 million to resolve claims that it offered illegal provider kickbacks to induce them to prescribe drugs Advicor and Niaspan, according to a Department of Justice (DOJ) press release.
According to the DOJ, the settlement resolves allegations that Kos offered and paid illegal kickbacks in the form of money, free travel, grants, honoraria, and other valuable goods and services to physicians, other medical professionals, physician groups, and managed care organizations.
The settlement also resolved claims that Kos illegally promoted the use of Advicor as first-line therapy for management of mixed dyslipidemias, a disruption of the lipids in the blood. The Food and Drug Administration did not approve Advicor for that use.
Kos also entered into a deferred prosecution agreement that charges the company with conspiring to violate the anti-kickback statute. Specifically, Kos made a series of payments to two physicians or a third-party intermediary in the form of sponsorship of continuing medical education classes in exchange for prescribing Kos products. Kos has agreed to pay a $3.36 million criminal fine as a condition of the deferred prosecution agreement. The DOJ agreed to the deferred prosecution based on Kos’ thorough internal investigation of the violations and reports to the department.
Want to receive articles like this one in your inbox? Subscribe to Compliance Monitor!
Related Products
-
Billing Alert for Long-Term Care
It's essential to know how to correctly submit your Medicare claims in order to get the reimbursement your facility...
-
Homecare Audit Prevention:
Home health care is under more layers of regulatory scrutiny than ever before. Plus, under health care reform, the...
-
Clinical Documentation Improvement
Hospitals are undoubtedly aware of how a quality clinical documentation improvement program can benefit their facility, but...
-
The Postacute Care Transfer Rule and Patient Status
During this two hour audio conference, Gloryanne Bryant will use case scenarios to help you increase your understanding of...
-
Stark Law, 2nd edition: A user's guide to achieving compliance
This updated version of HCPro's Stark Law best seller, first published in 2005—and now co-authored by former CMS Stark...
Most Popular
- Articles
-
- Q/A: Volume requirement for reporting hydration services
- HIPAA Q&A: Level of encryption needed for email
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- Identify potential Medicaid RAC target areas
- Capturing all necessary codes for IUD insertion and removal can be challenging
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- OB services: Coding inside and outside of the package
- Q/A: Coding infusions to correct low potassium levels
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- HIPAA Q&A: Level of encryption needed for email
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- CMS has reformulated payments for some bilateral procedures
- Q&A: Follow CMS' coding guidelines when using modifier -25
- Understand the spine to code back procedures correctly
- What does case-mix index mean to you?
- Catch up on what's new with injections and infusions
- New conflicts of interest create new challenges
- Q/A. One injection code or two?
- Searched